Your browser doesn't support javascript.
loading
Barriers to psychosocial oncology service utilization in patients newly diagnosed with head and neck cancer.
Cohen, Alexandra; Ianovski, Lola E; Frenkiel, Saul; Hier, Michael; Zeitouni, Anthony; Kost, Karen; Mlynarek, Alex; Richardson, Keith; Black, Martin; MacDonald, Christina; Chartier, Gabrielle; Rosberger, Zeev; Henry, Melissa.
Afiliação
  • Cohen A; McGill University, Montreal, Canada.
  • Ianovski LE; Jewish General Hospital, Montreal, Canada.
  • Frenkiel S; Jewish General Hospital, Montreal, Canada.
  • Hier M; McGill University, Montreal, Canada.
  • Zeitouni A; Jewish General Hospital, Montreal, Canada.
  • Kost K; McGill University Health Centre, Montreal, Canada.
  • Mlynarek A; McGill University, Montreal, Canada.
  • Richardson K; Jewish General Hospital, Montreal, Canada.
  • Black M; McGill University, Montreal, Canada.
  • MacDonald C; McGill University Health Centre, Montreal, Canada.
  • Chartier G; McGill University, Montreal, Canada.
  • Rosberger Z; McGill University Health Centre, Montreal, Canada.
  • Henry M; McGill University, Montreal, Canada.
Psychooncology ; 27(12): 2786-2793, 2018 12.
Article em En | MEDLINE | ID: mdl-30216594
ABSTRACT

OBJECTIVES:

While patients with head and neck cancer (HNC) are known to experience higher levels of anxiety and depression, they do not always use psychosocial oncology (PSO) services when available. This study aimed to investigate barriers to PSO service utilization in this patient population, with the goal of appropriately targeting outreach interventions.

METHODS:

A conceptual model based on the Behavioral Model of Health Services Use was tested in 84 patients newly diagnosed with a first occurrence of HNC followed longitudinally over 1 year, including variables collected through self-administered questionnaires, Structured Clinical Interviews for DSM (SCID-I), and medical chart reviews.

RESULTS:

Within the first-year post-diagnosis, 42.9% of HNC patients experienced clinical levels of psychological distress, with only 50% of these consulting PSO services (29% total). A logistic regression indicated that PSO utilization was increased when patients presented with advanced cancer (P = 0.04) and a SCID-I diagnosis of major depressive disorder, anxiety disorder, or substance use disorder (P = 0.02), while there was an inverse relationship with self-stigma of seeking help (P = 0.03); these variables together successfully predicted 76.3% of overall PSO utilization, including 90.6% of non-users.

CONCLUSIONS:

Future outreach interventions in patients with HNC could address stigma in an attempt to enhance PSO integration into routine clinical care.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ansiedade / Aceitação pelo Paciente de Cuidados de Saúde / Depressão / Comportamento de Busca de Ajuda / Neoplasias de Cabeça e Pescoço Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Psychooncology Assunto da revista: NEOPLASIAS / PSICOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ansiedade / Aceitação pelo Paciente de Cuidados de Saúde / Depressão / Comportamento de Busca de Ajuda / Neoplasias de Cabeça e Pescoço Tipo de estudo: Diagnostic_studies / Prognostic_studies / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Psychooncology Assunto da revista: NEOPLASIAS / PSICOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá